OTC · CIK 0001575142
BDPT BIOADAPTIVES, INC.
Insider trading from SEC Form 4. Last filing 7 d ago. Close $0.00 on Oct 9, 2026, +67% from the 52-week low and -97% from the high.
BIOADAPTIVES, INC. (BDPT) has 18 SEC Form 4 filings on file from 2 insiders, the latest filed on Oct 6, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at BDPT. The newest: Gimhana Sasanka Dissanayake (director) bought $11k of stock on Nov 22, 2024, filed Dec 3, 2024, scored 23 (weak).
BDPT closed at $0.00 on Oct 9, 2026, 67% above its 52-week low and 97% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BIOADAPTIVES, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Gimhana Sasanka Dissanayake director buy | $11k 125,000 shares | - | - |
Transactions
Every row filed, 22 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +15,625 | $0.00 | $0 | 155,265 | 7 d ago |
| Sep 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +35,715 | $0.00 | $0 | 139,640 | 40 d ago |
| Jun 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +4,717 | $0.00 | $0 | 76,271 | Jun 3, 2026 |
| May 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +4,808 | $0.00 | $0 | 71,554 | May 5, 2026 |
| Apr 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +4,386 | $0.00 | $0 | 66,746 | Apr 3, 2026 |
| Mar 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +2,578 | $0.00 | $0 | 62,360 | Mar 3, 2026 |
| Feb 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +2,565 | $0.00 | $0 | 59,779 | Feb 3, 2026 |
| Jan 1, 2026 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +2,286 | $0.00 | $0 | 57,217 | Jan 5, 2026 |
| Dec 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +2,025 | $0.00 | $0 | 54,931 | Dec 3, 2025 |
| Nov 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +1,382 | $0.00 | $0 | 52,906 | Nov 4, 2025 |
| Oct 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +1,517 | $0.00 | $0 | 51,524 | Oct 6, 2025 |
| Sep 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +1,506 | $0.00 | $0 | 50,007 | Sep 3, 2025 |
| Aug 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +1,307 | $0.00 | $0 | 48,501 | Aug 5, 2025 |
| Jul 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +847 | $0.00 | $0 | 47,194 | Jul 3, 2025 |
| Jun 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +713 | $0.00 | $0 | 46,347 | Jun 3, 2025 |
| May 1, 2025 | Mark P Frissora director | JOther Series D Convertible Preferred Stockderivative | +694 | $0.00 | $0 | 45,634 | May 23, 2025 |
| Feb 15, 2025 | Mark P Frissora director | AGrant or award Series D Convertible Preferred Stockderivative | +455 | $11.00 | $5,005 | 4,092 | May 5, 2025 |
| Mar 15, 2025 | Mark P Frissora director | AGrant or award Series D Convertible Preferred Stockderivative | +479 | $10.45 | $5,006 | 4,571 | May 5, 2025 |
| Apr 9, 2025 | Mark P Frissora director | POpen-market purchase Series D Convertible Preferred Stockderivative | +39,868 | $7.52 | $300k | 44,439 | May 5, 2025 |
| Apr 9, 2025 | Mark P Frissora director | POpen-market purchase Option to Purchase Common Stockderivative | +1 | - | - | 1 | May 5, 2025 |
| Apr 15, 2025 | Mark P Frissora director | AGrant or award Series D Convertible Preferred Stockderivative | +501 | $9.99 | $5,005 | 44,940 | May 5, 2025 |
| Nov 22, 2024 | Gimhana Sasanka Dissanayake director | POpen-market purchase Common | +125,000 | $0.09 | $11k | 125,000 | Dec 3, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Gimhana Sasanka Dissanayakedirector
- Mark P Frissoradirector
Questions about BDPT
Answered from the filings on this page, as of the latest one.
Are insiders buying BDPT?
No. In the last 90 days no insider at BIOADAPTIVES, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade BDPT on the open market?
Gimhana Sasanka Dissanayake (director) bought $11k of BDPT on Nov 22, 2024 and filed the Form 4 on Dec 3, 2024. InsiderTell scored 23 (weak).
How many insiders file Form 4 at BIOADAPTIVES, INC.?
2 people have filed a Form 4 at BIOADAPTIVES, INC., among them Gimhana Sasanka Dissanayake (director), Mark P Frissora (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.